Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Karyopharm Therapeutics Inc.

NASDAQ: KPTIQ · Life Sciences · 5 alerts · CIK 1503802

Share price
$0.0286Close, Nov 16
Market cap
$649K
Shares outstanding
22.68MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Karyopharm Therapeutics Inc. filings on SEC EDGAR ↗

4:15 PM ET 8-K
Loan & Debt

Karyopharm Therapeutics Debt Financing Update

Karyopharm Therapeutics has extended its existing Forbearance Agreement and Limited Waiver to Indentures from October 22, 2026, to November 1, 2026. This extension provides the company additional time to address its debt obligations while lenders agree to refrain from exercising certain rights or remedies during this period.

Term
through Nov 1, 2026
7:30 AM ET 8-K
Loan & Debt

Karyopharm Therapeutics Debt Financing Update

Karyopharm Therapeutics Inc. has extended its existing forbearance period under a Forbearance Agreement and Limited Waiver to Indentures. The expiration date of the forbearance period was moved from October 15, 2026, to October 22, 2026, providing the company additional time to address its debt obligations.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.